The biotech industry is expected to grow steadily due to advancements in medical technologies, personalized medicine, gene therapies, and government initiatives. While Harmony Biosciences Holdings, Inc. (HRMY) and Exelixis, Inc. (EXEL) could be ideal investments, Surrozen, Inc. (SRZN) might be best kept on hold.
The global biotechnology market is projected to grow at a CAGR of 14% until 2030. The market is driven by strong government support through initiatives aimed at the modernization of the regulatory framework, improvements in approval processes & reimbursement policies, as well as standardization of clinical studies.
